Audentes Therapeutics, Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 09/30/19 Q3

ended 06/30/19 Q2

ended 03/31/19 Q1

ended 12/31/18 FY 2018

ended 09/30/18 Q3

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Post-effective amendment to an automatic shelf registration

Updated info for already-effective prospectus

Updated info for already-effective prospectus

Ownership Filter

Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc.

Great Point Partners LLC

Redmile Group, LLC

PFM Health Sciences, LP

News Filter

Astellas Completes Acquisition of Audentes Therapeutics

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Astellas Enters Into Definitive Agreement to Acquire Audentes Therapeutics

Earnings Release or Operating Update, Financial Statements or Exhibits

Investor Presentation

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Notice of effectiveness

Letter from the SEC

Correspondence with the SEC

Letter from the SEC